Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice

  • The PLOS ONE Staff

There is an error in the fourth sentence of the “Experimental methods” section of the Materials and Methods. The corrected sentence should read: In total, 20 mg/kg/day of fenofibrate was administered to the treated db/db and db/m groups.

There are errors in the sixth sentence of the second paragraph of the Discussion. The corrected sentence should read: Recently, we demonstrated that the AMPK activator resveratrol improves lipotoxicity in the kidney by enhancing the PPARα-ERR-1α-SREBP-1-mediated removal of lipid accumulation and decreasing apoptotic renal cell death and oxidative stress related to FoxO3a dephosphorylation in diabetic nephropathy.

Reference

  1. 1. Hong YA, Lim JH, Kim MY, Kim TW, Kim Y, et al. (2014) Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice. PLoS ONE 9(5): e96147

Citation: The PLOS ONE Staff (2014) Correction: Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice. PLoS ONE 9(8): e105921. https://doi.org/10.1371/journal.pone.0105921

Published: August 11, 2014

Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.